{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:37:56Z","timestamp":1793644676767,"version":"4.5.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Carlos III Institute, Spanish Ministry of Science and Innovation","award":["CD13\/00149"],"award-info":[{"award-number":["CD13\/00149"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jad.2014.11.008","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T11:33:46Z","timestamp":1416224026000},"page":"211-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants"],"prefix":"10.1016","volume":"173","author":[{"given":"Dina","family":"Popovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Perugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2014.11.008_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/157488606775252593","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"1","author":"De las Cuevas","year":"2006","journal-title":"Curr. Drug Saf."},{"issue":"2","key":"10.1016\/j.jad.2014.11.008_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.euroneuro.2007.07.005","article-title":"A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder","volume":"18","author":"Papakostas","year":"2008","journal-title":"Eur. Neuropsychopharm."},{"issue":"8","key":"10.1016\/j.jad.2014.11.008_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jad.2014.11.008_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/JCP.0b013e31820ebd2c","article-title":"Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication","volume":"31","author":"McClintock","year":"2011","journal-title":"J. Clin. Psychopharm."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2014.11.008_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/13651500600552552","article-title":"The importance of long-term tolerability in achieving recovery","volume":"10","author":"Baldwin","year":"2006","journal-title":"Int. J. Psychiat. Clin. Prac"},{"issue":"1","key":"10.1016\/j.jad.2014.11.008_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4088\/JCP.13r08710","article-title":"Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice","volume":"75","author":"Papakostas","year":"2014","journal-title":"J. Clin. Psychiat."},{"issue":"5","key":"10.1016\/j.jad.2014.11.008_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/acps.12270","article-title":"The bipolar maze: a roadmap through translational psychopathology","volume":"129","author":"Vieta","year":"2014","journal-title":"Acta Psychiat. Scand."},{"key":"10.1016\/j.jad.2014.11.008_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eurpsy.2011.11.007","article-title":"The clinical implications of cognitive impairment and allostatic load in bipolar disorder","volume":"28","author":"Vieta","year":"2013","journal-title":"Eur. Psychiat."},{"issue":"8","key":"10.1016\/j.jad.2014.11.008_bib9","first-page":"864","article-title":"Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review","volume":"75","author":"Keefe","year":"2014","journal-title":"J. Clin. Psych.Psych."},{"key":"10.1016\/j.jad.2014.11.008_bib10","first-page":"1","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"30","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharm."},{"issue":"1","key":"10.1016\/j.jad.2014.11.008_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10401230490281618","article-title":"Tolerability issues during long-term treatment with antidepressants","volume":"16","author":"Cassano","year":"2004","journal-title":"Ann. Clin. Psychiat"},{"issue":"1","key":"10.1016\/j.jad.2014.11.008_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000012364","article-title":"Development of a brief screening instrument: the hands","volume":"69","author":"Baer","year":"2000","journal-title":"Psychother. Psyc."},{"key":"10.1016\/j.jad.2014.11.008_bib13","series-title":"Chemotherapy in Psychiatry. Pharmacologic Basis of Treatments for Major Mental Illness","first-page":"183","author":"Baldessarini","year":"2013"},{"key":"10.1016\/j.jad.2014.11.008_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000080392","article-title":"Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction","volume":"73","author":"Bolling","year":"2004","journal-title":"Psychother Psyc."},{"key":"10.1016\/j.jad.2014.11.008_bib15","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4088\/JCP.v65n0712","article-title":"Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate","volume":"65","author":"Hu","year":"2004","journal-title":"J. Clin. Psychiat."},{"issue":"11","key":"10.1016\/j.jad.2014.11.008_bib16","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"Fava","year":"2006","journal-title":"J. Clin. Psychiatr."},{"issue":"4","key":"10.1016\/j.jad.2014.11.008_bib17","first-page":"409","article-title":"Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues","volume":"10","author":"Kelly","year":"2008","journal-title":"Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jad.2014.11.008_bib19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.euroneuro.2009.11.009","article-title":"Antidepressants in healthy subjects: what are the psychotropic\/psychological effects? Eur","volume":"20","author":"Serretti","year":"2010","journal-title":"Neuropsychopharm"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714007095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032714007095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:14:56Z","timestamp":1759022096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032714007095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":18,"alternative-id":["S0165032714007095"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2014.11.008","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2014.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}